From Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights:

Gatekeeper answer and complaint

Gatekeeper answer and complaint—

Gatekeeper Pharmaceuticals answer to Dana-Farber’s complaint and complaint against Novartis, filed 10/15/10. Click icon above to download the pdf.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy Insight · Special Report
Biotech Startups: How to Succeed in a COVID-19 World
Industry experts explain what it takes to launch a new biotech company

Sponsored · Webinar
Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX

Xconomy on Demand

We offer a number of ways to subscribe for free!